skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Estimation of kinetic parameters for glucose transport in human brain cortex

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6795009

3-O-C-11-methyl-D-glucose (CMG), F-18-3-deoxy-3-fluoro D-glucose (3FDG), and dynamic positron-emission-tomography (dPET) were used to measure the rate constants for glucose transport across the blood brain barrier (BBB) in human cortex. The assay takes advantage of CMG or 3FDG being practically not metabolized in brain and being transported back from the tissue into the circulation. The simultaneous registration of tracer concentration in blood and tissue by dPET at 1 min intervals for 40 min yields time activity curves, which permit the in vivo determination of the rate constants for CMG or 3FDG transport across the BBB. In the present study, 4 healthy volunteers and 10 patients suffering from a single-sided ischemic brain disease were examined. In all cases the CMG/3FDG measurements were carried out at two different glucose plasma concentrations i.e. at normoglycemia and hyperglycemia after i.v. application of 10 g glucose. The determination of glucose plasma concentration was performed just before and immediately after the CMG/3FDG study. Using these data and a new mathematical model the Michaelis-Menten constant (K/sub M/) and maximal velocity (V/sub M/) for CMG, 3FDG and glucose transport across the BBB in normal and non-affected human cortex were determined. K/sub M CMG/ was 7.21 ..mu..mol/g; K/sub M 3FDG/ was 3.93 ..mu..mol/g and K/sub M gluc/ was 6.31 ..mu..mol/g. V/sub M/ was found in all cases to be 2.1 ..mu..mol/min g. The data obtained suggest that the CMG/3FDG method might provide a powerful tool for studying the mechanisms involved in the pathological alterations of glucose carrier system.

Research Organization:
Inst. of Medicine
OSTI ID:
6795009
Report Number(s):
CONF-850611-; TRN: 87-010682
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
Country of Publication:
United States
Language:
English